Academia-Industry Bridging Program for National Science and Technology Projects

Academia-Industry Bridging Program for National Science and Technology Projects is rated 3 out of 5 in the category biotechnology. Read and write reviews about Academia-Industry Bridging Program for National Science and Technology Projects. Academia-Industry Bridging Program (AIBP) manages the intellectual properties (IP) developed by national research programs in biotechnology & pharmaceuticals (the NSTPBP), genomic medicine (the NRPGM) and 3 major medical centers in Taiwan. Founded in 2006 by National Science and Technology Programs in Taiwan, AIBP handles both patentable inventions and biomaterials. Each licensing officer has technical trainings, most possess interdisciplinary backgrounds (law, finance, or IP) and spent dozen years in patent review, product development, project management and/or business development. AIBP manages invention disclosures from beginning to end, including evaluating the disclosures, assessing market and IP, backing patent filing, marketing, negotiating, and monitoring licensee performance. AIBP proactively seeks to foster the development of medical inventions through technology licensing and cooperative research between inventors and industry. Our charter is to help turn the scientific results into tangible products that address public benefit.